Telepractice Supported Delivery of LSVT®LOUD

Abstract

This article outlines the essential features and underlying principles of Lee Silverman Voice Treatment (LSVT®LOUD) and explores the delivery of this treatment via telepractice. A detailed summary of the core features of LSVT®LOUD and the principles underpinning this treatment are presented. Current evidence to support the feasibility and validity of synchronous and asynchronous delivery of LSVT®LOUD to people with Parkinson disease (PD) is reviewed. Technology specifications, cost-benefit analyses, and patient satisfaction are discussed. The challenges involved in delivery of LSVT®LOUD via telepractice, such as inconsistent audio and video quality during videoconferencing, accurate measurement of vocal parameters, technical skill level of the clinician, and patient candidacy, are highlighted. LSVT®LOUD can be effectively and reliably delivered via telepractice. Improvements in telecommunications are required to overcome some of the technology challenges encountered in this mode of delivery. Positive benefits of online treatment in relation to savings in time and money and reduced carer burden are emerging. Patient satisfaction with telepractice in the management of the speech disorder associated with PD is high. The uptake of LSVT®LOUD into telepractice is likely to steadily increase with advances in mobile technologies and web-based applications designed to deliver this treatment.